Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2009
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/08/2009WO2009124167A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124166A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123967A1 5,6,7,8-tetrahydroquinazolin-2-amine derivatives and related compounds as histamine h4 receptor modulators for the treatment of asthma
10/08/2009WO2009123948A2 Compounds and compositions as itpkb inhibitors
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121812A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
10/08/2009WO2009121791A1 CONVERSION OF TRYPTOPHAN INTO ß-CARBOLINE DERIVATIVES
10/08/2009WO2009098612A3 Polymorphic form of a [1, 2, 4] triazolo [4, 3-a] pyridine derivative for treating inflammatory diseases
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253738 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253737 Certain chemical entities, compositions, and methods
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253735 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
10/08/2009US20090253734 Inhibitors of akt activity
10/08/2009US20090253725 ACETYL CoA CARBOXYLASE INHIBITORS
10/08/2009US20090253696 Substituted pyrido(3,2-d) pyrimidines and pharmaceutical compositions for treating viral infections
10/08/2009US20090253695 Hydroxyalkyl Substituted Imidazonaphthyridines
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253677 HIV Integrase Inhibitors
10/08/2009US20090252779 Azaindazole compounds and methods of use
10/08/2009US20090252680 Novel compound with affinity for amyloid
10/08/2009US20090252679 Novel Compound Having Affinity for Amyloid
10/08/2009DE102008017591A1 Neue Materialien für organische Elektrolumineszenzvorrichtungen New materials for organic electroluminescent
10/08/2009CA2720490A1 Compounds and compositions as itpkb inhibitors
10/08/2009CA2719985A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719526A1 Conversion of tryptophan into .beta.-carboline derivatives
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107059A1 Conversion of tryptophan into ß-carboline derivatives
10/07/2009EP2106396A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/07/2009EP1915375B1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/07/2009CN101553488A Hypertension-ameliorating agent
10/07/2009CN101553487A Substituted 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-2-ol compounds and methods relating thereto
10/07/2009CN101553483A 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
10/07/2009CN101553474A Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
10/07/2009CN101550136A Diarylurea derivatives and application thereof used for preparing anti-neoplastic medicament
10/06/2009US7598666 Rubrene derivatives emit blue light; glass substrate supports a hole injecting layer, a hole transporting layer, and a light emitting layer
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598382 Immonomoderators; viricides; anticancer agents; for example, 2-Butyl-1-isobutyl-7-(thiophen-3-yl)-1H-imidazo[4,5-c]quinolin-4-amine; use of these compounds for inducing or inhibiting cytokine biosynthesis in animals
10/06/2009US7598377 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009US7598264 HIV integrase inhibitors
10/06/2009US7598259 mGluR1 antagonists as therapeutic agents
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009CA2427617C Medicinal compositions for concomitant use as anticancer agent
10/06/2009CA2419764C Process for preparing a substituted imidazopyridine compound
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/06/2009CA2258924C Cftr channel activator compounds and pharmaceutical compositions containing same
10/01/2009WO2009120720A1 Bridged heterocyclic compounds and methods of use
10/01/2009WO2009120717A2 Pyrido [3, 4-b] indoles and methods of use
10/01/2009WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009119085A1 Novel photosensitizer and photovoltaic element
10/01/2009WO2009118742A1 Doubly reduced perylene-diimides and supramolecular polymers derived from perylene-diimides
10/01/2009WO2009118655A2 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
10/01/2009WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009WO2009118175A1 Novel p2x7r antagonists and their use
10/01/2009WO2009118173A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009WO2009118169A1 Spiro(5.5)undecane derivatives
10/01/2009WO2009097287A9 Compounds and compositions as kinase inhibitors
10/01/2009WO2009095162A8 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
10/01/2009WO2009065922A3 Organic compounds
10/01/2009WO2009065919A3 Organic compounds
10/01/2009US20090247755 Process for Preparing a Substituted Imidazopyridine Compound
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247571 Certain Chemical Entities, Compositions and Methods
10/01/2009US20090247568 Aminopiperidinyl derivatives and uses thereof
10/01/2009US20090247561 Substituted spirocyclic cyclohexane derivatives
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247518 6-(2-alkyl-phenyl)-pyrido[2,3-d]pyrimidines useful as protein kinase inhibitors
10/01/2009US20090247517 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/01/2009US20090247516 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
10/01/2009US20090247514 Spirolactam aryl cgrp receptor antagonists
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247507 Enzyme Inhibitors
10/01/2009US20090247505 Spiro(5.5)undecane derivatives
10/01/2009US20090246772 Such as N'-Dibenzo[c,h][1,5]naphthyridin-6-ylmethyl-N,N-diethyl-propane-1,3-diamine; quantitative analysis; kits
10/01/2009US20090246198 Mapk/erk kinase inhibitors and methods of use thereof
10/01/2009US20090246169 Indolopyridines as eg5 kinesin modulators
10/01/2009US20090246147 Delivery Of Antipsychotics Through An Inhalation Route
10/01/2009US20090246134 Compositions and methods for modulating gated ion channels
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2719745A1 Novel p2x7r antagonists and their use
10/01/2009CA2719742A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009CA2719736A1 Spiro(5.5)undecane derivatives
10/01/2009CA2719544A1 Novel substituted imidazoquinolines
10/01/2009CA2719477A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009CA2719412A1 Pyrido[3,4-b]indoles and methods of use
10/01/2009CA2718790A1 Bridged heterocyclic compounds and methods of use
10/01/2009CA2718727A1 Heterocyclic compound
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 646